Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy

NCT05675319 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
28
Enrollment
OTHER
Sponsor class

Stopped The reason for the end of recruitment is that the recruitment target could not be achieved despite all efforts and the G-BA (financing party) does not consider a continuation of the AlloRelapseMM study to be expedient.

Conditions

Interventions

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Collaborators